Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Trancura Biosciences
AddedMar 20, 2024
UpdatedJun 18, 2026
Trancura Biosciences

Trancura Biosciences

Innovative biotech in Emeryville, CA, using genomics for antibody design.

HQ
Emeryville, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees

Trancura Biosciences is a biotechnology company that uses targeted genomic approaches for the de nov design of monoclonal antibodies.

The company develops efficient screenings based on molecular immune profiling to accelerate the discovery of new monoclonal antibodies for biomedical relevant molecular targets. The company is headquartered in Emeryville, California.

Trancura Biosciences - Similar Companies

OmniAb logo

OmniAb

omniab.com

Dren Bio logo

Dren Bio

drenbio.com

RevMAb Biosciences logo

RevMAb Biosciences

revmab.com

Global Bio logo

Global Bio

Transcera logo

Transcera

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

AltruBio logo

AltruBio

Abterra Biosciences logo

Abterra Biosciences

abterrabio.com

Trellis Bioscience logo

Trellis Bioscience

trellisbio.com

BioLoomics logo

BioLoomics

bioloomics.com

Macromoltek logo

Macromoltek

macromoltek.com

Triveni Bio logo

Triveni Bio

triveni.bio

AbCellera Biologics logo

AbCellera Biologics

abcellera.com

Transomic Technologies logo

Transomic Technologies

Scribe Biosciences logo

Scribe Biosciences

Trancura Biosciences - Quick Facts

Who are Trancura Biosciences' competitors?

Companies similar to Trancura Biosciences include OmniAb, Dren Bio, RevMAb Biosciences and Global Bio.

When was Trancura Biosciences founded?

Trancura Biosciences was founded in 2019.

Where is Trancura Biosciences' headquarters located?

Trancura Biosciences' headquarters is located in Emeryville, CA, US.

When was Trancura Biosciences' last funding round?

Trancura Biosciences' most recent funding round was for $971.7k (USD) in January 2022.

How much has Trancura Biosciences raised to-date?

As of Jan 7, 2022, Trancura Biosciences has raised a total of $971.7k (USD).

How many employees does Trancura Biosciences have?

Trancura Biosciences has 5 employees as of Feb 5, 2024.

Trancura Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibodies
  • Genomics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software